PHARMACOL RES 润色咨询

PHARMACOLOGICAL RESEARCH

出版年份:1989 年文章数:3070 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2020-12-12 ms1000001706153386

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:一审15天,一周修回,2小时后accept,效率奇高

    20

    展开20条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    18小时前 ms4000000344618620 来自浙江省

    这个杂志今年为什么掉到中科院医学2区呢,降区很突然

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2020-12-02 泪湿青衣

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:一审20天,给了一个月修回,修回后第二天立马接收了

    33

    展开33条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2024-04-16 小胖子罗军 来自上海

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:中药单体
    经验分享:不收植物提取小分子的文章了,让改投到子刊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2024-01-27 P拾荒者 来自浙江省

    偏重的研究方向:肿瘤
    经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况

    15

    展开15条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2024-01-03 1225de92m39暂无昵称 来自广东省

    请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗?

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2023-11-01 ms1000000150741111 来自上海

    10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2023-06-03 1473ac4am82暂无昵称 来自四川省

    偏重的研究方向:肿瘤
    经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命

    10

    展开10条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2024-02-28 不死鸟的飞翔 来自重庆

    偏重的研究方向:肿瘤
    经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=907230, encodeId=739690e230a7, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:一审15天,一周修回,2小时后accept,效率奇高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=481b5433585, createdName=ms1000001706153386, createdTime=Sat Dec 12 08:24:55 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198928, encodeId=cfdd2198928e0, content=这个杂志今年为什么掉到中科院医学2区呢,降区很突然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0d515571355, createdName=ms4000000344618620, createdTime=Wed Apr 17 11:23:58 CST 2024, time=18小时前, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=904282, encodeId=6701904282d8, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:一审20天,给了一个月修回,修回后第二天立马接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=360, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/j8ZDGGwXviarvaQUrTnwMAOacKbibaUNYPklS9cSMRgJw3U6lS6gcOeXyON2j21ichZw1g7CU9qdYwnK7sPy0RWLQ/132, createdBy=3fb82251429, createdName=泪湿青衣, createdTime=Wed Dec 02 12:45:00 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198813, encodeId=96182198813b7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体<br>经验分享:不收植物提取小分子的文章了,让改投到子刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Apr 16 15:04:05 CST 2024, time=2024-04-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2184291, encodeId=f8662184291c8, content=偏重的研究方向:肿瘤<br>经验分享:邀请了8个审稿人,一周了没人接受审稿,哎,啥个情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Sat Jan 27 14:40:45 CST 2024, time=2024-01-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2178950, encodeId=e31a21e895082, content=请问这个杂志里的author checklist中的两个勾选框分别是for Meta-analyses only和for studies with bioactive molecules,若我文章不属于这两项内容,这两个框框还需要进行勾选吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04202326131, createdName=1225de92m39暂无昵称, createdTime=Wed Jan 03 09:18:31 CST 2024, time=2024-01-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2166009, encodeId=2e03216600943, content=10月20日提交,当天过了大约两小时就with editor了,然后一直到11月1号还是没动静。请问这是送审了没更新状态还是编辑把这篇文章遗忘处理了呢?有小伙伴有过类似的情况吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=104e5520464, createdName=ms1000000150741111, createdTime=Wed Nov 01 09:10:36 CST 2023, time=2023-11-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2140666, encodeId=e32f2140666ae, content=偏重的研究方向:肿瘤<br>经验分享:综述,周五晚上9点提交的,周6就under review了是什么情况...慌得要命, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cb15200587, createdName=1473ac4am82暂无昵称, createdTime=Sat Jun 03 20:16:09 CST 2023, time=2023-06-03, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189895, encodeId=341f21898954f, content=偏重的研究方向:肿瘤<br>经验分享:刚接收了1篇,审稿1个月,给了2个月修改的时间,周末修回,3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=babe1645573, createdName=不死鸟的飞翔, createdTime=Wed Feb 28 15:21:35 CST 2024, time=2024-02-28, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167251, encodeId=70cf216e25160, content=请问综述的checklist有模板吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07035603044, createdName=ms7000001072468055, createdTime=Tue Nov 07 17:36:45 CST 2023, time=2023-11-07, status=1, ipAttribution=北京)]
    2023-11-07 ms7000001072468055 来自北京

    请问综述的checklist有模板吗?

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分